Strength in numbers is a common theme of this pandemic. But some firms, particularly in the health-care field, aren’t waiting for the crisis to lift before throwing in their lot with others.
New York-based Tauriga Sciences, Inc. (OTC:TAUG) and San Diego-based Aegea Biotechnologies, will be collaborating on a rapid, multiplexed COVID-19 (novel coronavirus) test designed to have superior sensitivity and selectivity.
This PCR-based test will measure the SARS-CoV-2 virus from nasal (or other) swabs by utilizing Aegea’s patented and clinically validated technologies, including Selector Technology, which have been cross-licensed and used in over 15,000 oncology patient samples to successfully detect ultra-rare mutations. In existing assays Aegea’s patented technologies demonstrate exquisite specificity and very high sensitivity.
TAUG shares sprouted wings late in Tuesday’s session, gaining just more than two cents, which amounts to 55.2%, to 5.81 cents, on 8.6 million.
Meantime, Vancouver-based NewLeaf Brands Inc. (CSE:NLB) signed a letter of intent Monday to acquire Colorado-based Mydecine Group, a vertically integrated company engaged to utilize the vast medicinal, health and wellness capabilities of the many compounds found in various strains of mushroom and fungi as a whole.
The latter company aims to be an industry pioneer in the cultivation, processing, product development, and research and development of the many beneficial and exciting compounds that are found in various strains of mushroom and fungi from all around the world.
Numerous compounds found in various strains of mushroom and fungi are already being used to develop treatments for health conditions such as depression, PTSD and opiate addiction. Meanwhile, in 2019, the National Alliance on Mental Illness had stated that one in six youths aged six-17 in the U.S. experiences a mental health disorder each year and one in 25 U.S. adults experiences a serious mental illness each year.
NLB moved into Tuesday’s final hour of trade up three cents, or 31.6%, to 12.5 cents, on 994,000 shares.
